[Effect of a tyrosine kinase inhibitors in a patient with a metastatic gastrointestinal stromal tumor].
Huguier
M
M
D001549:Benzamides; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D009372:Neoplasms, Connective Tissue / Q000188:drug therapy* / Q000556:secondary*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D010879:Piperazines; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011743:Pyrimidines / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D017154:Stromal Cells
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases
Effet d'un inhibiteur de la tyrosine kinase chez un malade ayant une tumeur stromale métastatique digestive.